Literature DB >> 12878163

Identification of Tyr900 in the kinase domain of c-Kit as a Src-dependent phosphorylation site mediating interaction with c-Crk.

Johan Lennartsson1, Christer Wernstedt, Ulla Engström, Ulf Hellman, Lars Rönnstrand.   

Abstract

We have previously demonstrated that ligand-stimulation of c-Kit induces phosphorylation of Tyr568 and Tyr570 in the juxtamembrane region of the receptor, leading to recruitment, phosphorylation and activation of members of the Src family of tyrosine kinases. In this paper, we demonstrate that members of the Src family of tyrosine kinases are able to phosphorylate c-Kit selectively on one particular tyrosine residue, Tyr900, located in the second part of the tyrosine kinase domain. In order to identify potential docking partners of Tyr900, a synthetic phosphopeptide corresponding to the amino acid sequence surrounding Tyr900 was used as an affinity matrix. By use of MALDI-TOF mass spectrometry, CrkII was identified as a protein that specifically bound to Tyr900 in a phosphorylation dependent manner, possibly via the p85 subunit of PI3-kinase. Expression of a mutant receptor where Tyr900 had been replaced with a phenylalanine residue (Y900F) resulted in a receptor with reduced ability to phosphorylate CrkII. Together these data support a model where c-Src phosphorylates the receptor, thereby creating docking sites for SH2 domain containing proteins, leading to recruitment of Crk to the receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878163     DOI: 10.1016/s0014-4827(03)00206-4

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.

Authors:  Amie S Corbin; Thomas O'Hare; Zhimin Gu; Ira L Kraft; Anna M Eiring; Jamshid S Khorashad; Anthony D Pomicter; Tian Y Zhang; Christopher A Eide; Paul W Manley; Jorge E Cortes; Brian J Druker; Michael W Deininger
Journal:  Cancer Res       Date:  2013-07-25       Impact factor: 12.701

Review 2.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

3.  Phosphorylation of the activation loop tyrosine 823 in c-Kit is crucial for cell survival and proliferation.

Authors:  Shruti Agarwal; Julhash U Kazi; Lars Rönnstrand
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

4.  Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2013-03-19       Impact factor: 6.603

5.  Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.

Authors:  Cecilia Herraiz; Fabrice Journé; Zalfa Abdel-Malek; Ghanem Ghanem; Celia Jiménez-Cervantes; José C García-Borrón
Journal:  Mol Endocrinol       Date:  2010-11-17

Review 6.  A survival Kit for pancreatic beta cells: stem cell factor and c-Kit receptor tyrosine kinase.

Authors:  Zhi-Chao Feng; Matthew Riopel; Alex Popell; Rennian Wang
Journal:  Diabetologia       Date:  2015-02-03       Impact factor: 10.122

7.  Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected.

Authors:  Grigoriy Koytiger; Alexis Kaushansky; Andrew Gordus; John Rush; Peter K Sorger; Gavin MacBeath
Journal:  Mol Cell Proteomics       Date:  2013-01-28       Impact factor: 5.911

8.  Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3.

Authors:  De-Chen Lin; Tong Yin; Maya Koren-Michowitz; Ling-Wen Ding; Saskia Gueller; Sigal Gery; Takayuki Tabayashi; Ulla Bergholz; Julhash U Kazi; Lars Rönnstrand; Carol Stocking; H Phillip Koeffler
Journal:  Blood       Date:  2012-08-31       Impact factor: 22.113

Review 9.  Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Authors:  Maryam Abbaspour Babaei; Behnam Kamalidehghan; Mohammad Saleem; Hasniza Zaman Huri; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2016-08-01       Impact factor: 4.162

10.  C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways.

Authors:  Bathri N Vajravelu; Kyung U Hong; Tareq Al-Maqtari; Pengxiao Cao; Matthew C L Keith; Marcin Wysoczynski; John Zhao; Joseph B Moore; Roberto Bolli
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.